hpCasMINI: An engineered hypercompact CRISPR-Cas12f system with boosted gene editing activity
Shufeng Ma(First Affiliated Hospital of Guangzhou Medical University), Zhili Rong(Southern Medical University)
Cited by 5
Related Papers
MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression <i>in vivo</i>
|Nucleic Acids Research|2021|54
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
|BMC Biology|2022|52
OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients
|Protein & Cell|2021|16
Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids
|Journal of Investigative Dermatology|2023|12